MobiHealth News November 17, 2023
Also, H2U has received strategic investment to take on the South Korean market.
Neurophet scores $15M in Series C funding, announces 2024 IPO
South Korean company Neurophet, a provider of brain image analysis software, has raised 20 billion won ($15 million) in a Series C funding round participated by institutional investors, such as KB Securities, Mirae Asset Securities, and IBK Industrial Bank of Korea.
This brings its total investments since its founding in 2016 to 50 billion won ($39 million).
Neurophet has developed software that can automatically analyse PET and MRI scans to detect biomarkers of Alzheimer’s disease, including amyloid beta protein and tau protein. The Neurophet SCALE PET can also monitor amyloid-related imaging abnormalities or ARIA, observed in patients...